Before the start of the ESMO congress, MEDSIR has brought together scientists, researchers, pharmaceutical companies, and patient association representatives to…
Preliminary immunogenicity results demonstrate induction of cancer antigen-specific T-cell responses in 77% of evaluable patients following CVGBM monotherapy84% of immune…
SEATTLE WA and LUND, SWEDEN / ACCESSWIRE / September 13, 2024 / Aptevo Therapeutics ("Aptevo") (NASDAQ:APVO) and Alligator Bioscience AB…
- New CFO Brings Multiple Years of Experience from Biotech Companies- As Part of the New Hire, the Company Issues…
BOSTON, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing…
Kevin Riley, industry leader with global experience in technology commercialization, joins as presidentCarolyn Magill steps down as CEO; Jeremy Rassen,…
As the stage is set for another year of groundbreaking research and transformative treatment advancements, several companies are seizing the…
FREMONT, Calif., Sept. 12, 2024 /PRNewswire/ -- The 34th Medical Informatics Europe Conference was held in Athens, Greece August 25-29, 2024.…
Company Leverages Causal Machine Learning to Overcome Key Challenges in Developing New Cancer Treatments BOSTON, Sept. 12, 2024 /PRNewswire/ --…
Research presented will include the applications of new diagnostic tools and machine learning multimodal signatures in clinical trials BOSTON and…